On October 6, 2015, at 26 years old, I was diagnosed with acute myeloid leukemia (AML). A month later, I was in remission. I completed six months of chemotherapy and am so grateful to be back at my normal life.
Christine Attia knows first-hand how overwhelming and terrifying a blood cancer diagnosis can be. She lost her 27-year-old fiancé three years ago after a courageous six-month battle with acute myeloid leukemia (AML), a blood cancer which has seen few improvements in treatments in more than 40 years.
In 1995, Michael’s daughter Carley was diagnosed with acute myeloid leukemia (AML), M-7 – a rare form of blood cancer – at just two and a half years old. For the following year, Michael and his wife, Liz, practically lived at Rady Children’s Hospital in San Diego while Carley underwent heavy chemotherapy treatment.
“Hola,” I said playfully, as I answered my cell phone on a beautiful Saturday -- April 21, 2012.
Robert Hromas, M.D., a blood cancer expert at the University of Florida's College of Medicine, is looking to discover new drugs that will improve the response of elderly AML patients to chemotherapy.